Tredan O, Corset V, Wang Q, et al. Routine molecular screening of advanced refractory cancer patients: An analysis of the first 2490 patients of the ProfilER Study. J Clin Oncol. 35, 2017 (suppl; abstr LBA100).
Trastuzumab deruxtecan bij eerder behandelde HER2-positieve maagkanker
aug 2020 | Maag-darm-leveroncologie